Login
Navigate Fool.com
Will MITI beat
the market?

Micromet, Inc.

NASDAQ: MITI

Community Rating: 2 Stars: Unattractive

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$0.69

How do you think MITI
will perform against the market?

Top MITI Bull/Bear Pitches

 

efarev (< 20)
Submitted March 5, 2011

At 5.66, MITI is most definitely on sale. Early results in Acute lymphoblastic leukemia (ALL) look very promising and as more data is released over the next year, the stock should climb from this lev … More

0 Replies Reply Report this Post
 

TheParadox (< 20)
Submitted September 24, 2008

The worst company on earth.

0 Replies Reply Report this Post

News & Commentary Rss Feed

Make Money in Buyback Achievers the Easy Way

This fund sports a solid track record.

Judge Declines To Block Amgen Purchase Of Micromet -AP

Micromet Shareholder Group Asks Judge To Delay Purchase By Amgen -AP

Not Just Any Biotech Stock Will Do

Amgen a Step Closer to Micromet - Analyst Blog

Amgen Upped to Outperform - Analyst Blog

Has Amgen Become the Perfect Stock?

Finding companies that have all the right stuff can produce winners.

The Week's Top Stock Gainers

It was a relatively lackluster week for stocks, but some managed to post some serious gains.

2 Biotech Acquisitions in 1 Day! Let's Throw a Party

Amgen and Celgene pull the trigger. Don't drop the keg.

UPDATE: Amgen 4Q Profit Falls 9% On Tax Impacts, Charges

See More MITI News...

Sector

Healthcare

Industry

Biotechnology

Micromet, Inc. (MITI) Description

Website:

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks